Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Pratt

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Digital Journal of Ophthalmology : DJO|June 22, 2026
Silent sicklers and traumatic hyphema: the importance of maintaining a high index of suspicionJames Pratt, Caroline H Kerrison, Richard Yi, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Nuclear tau aggregates inhibit RNA export and form by secondary seeding from cytosolic tau aggregatesCarolyn J Decker, Kathleen McCann, Evan Lester, et al.
Journal of Clinical Pathology|June 28, 2020
Analysis of real-world PD-L1 IHC 28-8 and 22C3 pharmDx assay utilisation, turnaround times and analytical concordance across multiple tumour typesGabriel S Krigsfeld, Emily A Prince, James Pratt, et al.
Blood Cancer Journal|April 30, 2021
Sensitive multiple myeloma disease monitoring by mass spectrometryRasa Santockyte, Chelsea Jin, James Pratt, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2023
Cytosolic condensates rich in polyserine define subcellular sites of tau aggregationEvan Lester, Meaghan Van Alstyne, Kathleen L McCann, et al.
Cancer Chemotherapy and Pharmacology|September 16, 2008
Mechanistic population pharmacokinetics of total and unbound paclitaxel for a new nanodroplet formulation versus Taxol in cancer patientsJürgen B Bulitta, Ping Zhao, Robert D Arnold, et al.
Cancer Chemotherapy and Pharmacology|September 16, 2008
Multiple-pool cell lifespan models for neutropenia to assess the population pharmacodynamics of unbound paclitaxel from two formulations in cancer patientsJürgen B Bulitta, Ping Zhao, Robert D Arnold, et al.
Journal for Immunotherapy of Cancer|November 30, 2023
Evaluation of tissue- and plasma-derived tumor mutational burden (TMB) and genomic alterations of interest in CheckMate 848, a study of nivolumab combined with ipilimumab and nivolumab alone in patients with advanced or metastatic solid tumors with high TMBJie He, Natallia Kalinava, Parul Doshi, et al.
Cells|November 13, 2025
Polo-like Kinase 1 Activation Regulates Angiotensin II-Induced Contraction in Pudendal and Small Mesenteric Arteries from MiceRaiana Anjos Moraes, Olufunke O Arishe, James Pratt, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 16, 2023
High Interobserver Variability Among Pathologists Using Combined Positive Score to Evaluate PD-L1 Expression in Gastric, Gastroesophageal Junction, and Esophageal AdenocarcinomaMarie E Robert, Josef Rüschoff, Bharat Jasani, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Digital Journal of Ophthalmology : DJO|June 22, 2026
Silent sicklers and traumatic hyphema: the importance of maintaining a high index of suspicionJames Pratt, Caroline H Kerrison, Richard Yi, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Nuclear tau aggregates inhibit RNA export and form by secondary seeding from cytosolic tau aggregatesCarolyn J Decker, Kathleen McCann, Evan Lester, et al.
Journal of Clinical Pathology|June 28, 2020
Analysis of real-world PD-L1 IHC 28-8 and 22C3 pharmDx assay utilisation, turnaround times and analytical concordance across multiple tumour typesGabriel S Krigsfeld, Emily A Prince, James Pratt, et al.
Blood Cancer Journal|April 30, 2021
Sensitive multiple myeloma disease monitoring by mass spectrometryRasa Santockyte, Chelsea Jin, James Pratt, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2023
Cytosolic condensates rich in polyserine define subcellular sites of tau aggregationEvan Lester, Meaghan Van Alstyne, Kathleen L McCann, et al.
Cancer Chemotherapy and Pharmacology|September 16, 2008
Mechanistic population pharmacokinetics of total and unbound paclitaxel for a new nanodroplet formulation versus Taxol in cancer patientsJürgen B Bulitta, Ping Zhao, Robert D Arnold, et al.
Cancer Chemotherapy and Pharmacology|September 16, 2008
Multiple-pool cell lifespan models for neutropenia to assess the population pharmacodynamics of unbound paclitaxel from two formulations in cancer patientsJürgen B Bulitta, Ping Zhao, Robert D Arnold, et al.
Journal for Immunotherapy of Cancer|November 30, 2023
Evaluation of tissue- and plasma-derived tumor mutational burden (TMB) and genomic alterations of interest in CheckMate 848, a study of nivolumab combined with ipilimumab and nivolumab alone in patients with advanced or metastatic solid tumors with high TMBJie He, Natallia Kalinava, Parul Doshi, et al.
Cells|November 13, 2025
Polo-like Kinase 1 Activation Regulates Angiotensin II-Induced Contraction in Pudendal and Small Mesenteric Arteries from MiceRaiana Anjos Moraes, Olufunke O Arishe, James Pratt, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 16, 2023
High Interobserver Variability Among Pathologists Using Combined Positive Score to Evaluate PD-L1 Expression in Gastric, Gastroesophageal Junction, and Esophageal AdenocarcinomaMarie E Robert, Josef Rüschoff, Bharat Jasani, et al.
Pageof 3